AUS
NZ
UK
CA
USA
IND
Health
Danaher (NYSE:DHR) Stock Little Changed in Life Sciences Sector
December 29, 2025 06:02 AM PST| By Anmol KhazanchiFactual insight into Danaher Corporation activities across life sciences, diagnostics, and applied solutions, highlighting manufacturing integration, digital systems, and positioning within the Russell 1000 index.
SOPHiA GENETICS SA (NASDAQ:SOPH) Nasdaq Today Clinical AI Expansion
December 29, 2025 12:00 AM PST| By Anmol KhazanchiSOPHiA GENETICS (NASDAQ:SOPH) strengthens genomic and radiomic intelligence through cloud-native platforms and artificial intelligence, appearing in healthcare technology discussions shaped by nasdaq today.
Design Therapeutics, Inc. (NASDAQ:DSGN) Nasdaq Futures Neurology Programs
December 29, 2025 12:00 AM PST| By Anmol KhazanchiDesign Therapeutics develops small molecule treatments for inherited genetic diseases using its GeneTAC platform, appearing in broader biotechnology discussions influenced by activity associated with nasdaq futures.
Insulet Corporation (NASDAQ:PODD) Nasdaq Index Connected Care Ecosystem
December 29, 2025 12:00 AM PST| By Anmol KhazanchiInsulet Corporation develops tubeless insulin delivery systems through its Omnipod platform, supporting diabetes management and appearing in broader healthcare discussions linked to the nasdaq index.
Halozyme Therapeutics (NASDAQ:HALO) Nasdaq Composite Biopharma Platform
December 29, 2025 12:00 AM PST| By Anmol KhazanchiHalozyme Therapeutics develops drug-delivery platforms enabling subcutaneous biologic therapies, maintaining visibility in biopharmaceutical discussions connected to the nasdaq composite and innovation-focused healthcare sectors.
Incyte Corporation (NASDAQ:INCY) Nasdaq Index Fund Pathway Science
December 29, 2025 12:00 AM PST| By Anmol KhazanchiIncyte Corporation (NASDAQ:INCY) develops and commercializes novel oncology and inflammation therapies, appearing in broader healthcare and biotechnology conversations that include the Nasdaq index fund.
SOPHiA GENETICS (NASDAQ:SOPH) Within Nasdaq Futures Focus
December 29, 2025 12:00 AM PST| By Anmol KhazanchiSOPHiA GENETICS (NASDAQ:SOPH) advances cloud-native genomic analytics and AI-driven clinical workflows, appearing in broader healthcare technology discussions connected to movements in nasdaq futures.
Monopar Therapeutics (NASDAQ:MNPR) Sharpens Focus on Molecular Targeting
December 29, 2025 12:00 AM PST| By Anmol KhazanchiMonopar Therapeutics (NASDAQ:MNPR) is a clinical-stage biotechnology company developing targeted radiotherapeutics and next-generation antibody-drug conjugates to enhance precision in cancer treatment.
Precigen (NASDAQ:PGEN) Advances Genetic Medicine Platforms
December 29, 2025 12:00 AM PST| By Anmol KhazanchiPrecigen (NASDAQ:PGEN) focuses on genetic medicines through proprietary gene and cell therapy platforms, supporting targeted treatments across oncology, infectious diseases, and rare medical conditions.
CeriBell Corp (NASDAQ:CBLL) Develops Integrated Hearing Solutions
December 29, 2025 12:00 AM PST| By Anmol KhazanchiCeriBell Corp (NASDAQ:CBLL) delivers automated newborn hearing screening solutions using OAE and ABR technologies, supporting early detection of auditory impairments across hospitals and clinical settings.
Glaukos Corp (NYSE:GKOS) Shares Rise After Quarterly Results
December 24, 2025 08:07 AM PST| By Anmol KhazanchiGlaukos Corporation (NYSE:GKOS) provides MIGS devices and drug-delivery technologies, combining precision medical engineering with innovative solutions for chronic eye disease management.
Pfizer Inc (NYSE:PFE) Advances Biopharmaceutical Operations Globally
December 24, 2025 08:00 AM PST| By Anmol KhazanchiPfizer Inc (NYSE:PFE) demonstrates operational strength in medicines and vaccines, with consistent quarterly earnings, global manufacturing, and structured dividend distribution in the biopharmaceutical sector.
Pfizer (NYSE:PFE) Shares Flat After Clinical Update Disclosure
December 24, 2025 04:45 AM PST| By Anmol KhazanchiAn overview of Pfizer Inc operations, research activity, manufacturing reach, and sector classification, highlighting its role within healthcare and references such as the S&P 500.
National Research Corp (NASDAQ:NRC) Nasdaq 100 Index Health Metrics
December 24, 2025 12:00 AM PST| By Anmol KhazanchiVEON delivers mobile, broadband, and digital services across emerging markets through its operating subsidiaries, maintaining visibility in broader market discussions connected to the nasdaq 100 index.
Arcellx Inc (NASDAQ:ACLX) Nasdaq Composite Platform-Driven Biotech
December 24, 2025 12:00 AM PST| By Anmol KhazanchiArcellx (NASDAQ:ACLX) develops modular cell therapy platforms focused on oncology and immune control, maintaining visibility in biotechnology conversations shaped by the nasdaq composite.
United Therapeutics (NASDAQ:UTHR) Nasdaq Index Targeted Biotech
December 24, 2025 12:00 AM PST| By Anmol KhazanchiUnited Therapeutics (NASDAQ:UTHR) strengthens specialized healthcare through targeted therapies for rare conditions, remaining prominent in biotechnology discussions shaped by activity across the nasdaq index.
AtriCure Inc (NASDAQ:ATRC) Nasdaq Index Medical Device Depth
December 24, 2025 12:00 AM PST| By Anmol KhazanchiAtriCure (NASDAQ:ATRC) develops specialized medical devices for cardiac rhythm disorders, remaining visible in healthcare conversations shaped by activity connected to the nasdaq index.
Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech
December 24, 2025 12:00 AM PST| By Anmol KhazanchiMasimo (NASDAQ:MASI) supports global healthcare through noninvasive monitoring technologies, appearing in broader market conversations shaped by developments within the nasdaq 100 composition.
Masimo Corporation (NASDAQ:MASI) Nasdaq 100 Composition Health Tech
December 24, 2025 12:00 AM PST| By Anmol KhazanchiMasimo (NASDAQ:MASI) supports global healthcare through noninvasive monitoring technologies, appearing in broader market conversations shaped by developments within the nasdaq 100 composition.
Innoviva Inc (NASDAQ:INVA) Nasdaq Composite ETF Therapy Royalties
December 24, 2025 12:00 AM PST| By Anmol KhazanchiInnoviva (NASDAQ:INVA) operates as a royalty-focused life sciences company tied to respiratory therapies, appearing in broader biotechnology conversations shaped by the nasdaq composite etf.
